World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
16387
World Ranking
2239
National Ranking
1083

Paul L. Fidel publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul L. Fidel sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 200 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul L. Fidel D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul L. Fidel sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul L. Fidel is affiliated with the Louisiana State University Health Sciences Center New Orleans in the United States. Their research primarily falls within the fields of Medicine and Immunology and Microbiology. Specific subfields of study include Immunology, Infectious Diseases, Public Health, Environmental and Occupational Health, Physiology, and Molecular Biology.

The research topics addressed by Paul L. Fidel include:

  • Antifungal resistance and susceptibility
  • Immune responses and vaccinations
  • Antimicrobial Resistance in Staphylococcus
  • HIV/AIDS oral health manifestations
  • Oral microbiology and periodontitis research
  • Reproductive System and Pregnancy
  • Asthma and respiratory diseases

Paul L. Fidel has contributed to a number of research papers, among which the following are notable:

  • Could an Unrelated Live Attenuated Vaccine Serve as a Preventive Measure To Dampen Septic Inflammation Associated with COVID-19 Infection? (2020, mBio)
  • Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses (2021, mBio)

Other significant publications in the wider research network include:

  • A small molecule produced by Lactobacillus species blocks Candida albicans filamentation by inhibiting a DYRK1-family kinase (2021, Nature Communications)
  • Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients (2020, mBio)
  • Structural and functional analysis of EntV reveals a 12 amino acid fragment protective against fungal infections (2022, Nature Communications)

The most frequent publication venues for Paul L. Fidel are mBio, where they have published eight papers, and Nature Communications with four publications. Other venues include Infection and Immunity, Journal of Visualized Experiments, and bioRxiv (Cold Spring Harbor Laboratory).

Frequent co-authors collaborating with Paul L. Fidel include:

  • Mairi C. Noverr (16 publications)
  • Elizabeth A. Lilly (11 publications)
  • Junko Yano (10 publications)
  • Shannon K. Esher (5 publications)
  • Michael E. Hagensee (4 publications)

Best Publications

  • Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans

    Paul L. Fidel;Jose A. Vazquez;Jack D. Sobel

  • Requirement of Interleukin-17A for Systemic Anti-Candida albicans Host Defense in Mice

    Weitao Huang;Li Na;Paul L. Fidel;Paul Schwarzenberger

  • Immunopathogenesis of recurrent vulvovaginal candidiasis

    Fidel Pl;Sobel Jd

  • The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and Gram stain in patients with preterm labor and intact membranes

    Roberto Romero;Bo Hyun Yoon;Moshe Mazor;Ricardo Gomez

  • Association of Atopobium vaginae , a recently described metronidazole resistant anaerobe, with bacterial vaginosis

    Michael J Ferris;Alicia Masztal;Kenneth E Aldridge;J Dennis Fortenberry

  • An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.

    Paul L. Fidel;Melissa Barousse;Terri Espinosa;Mercedes Ficarra

  • Effects of Reproductive Hormones on Experimental Vaginal Candidiasis

    Paul L. Fidel;Jessica Cutright;Chad Steele

  • Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice

    Paul L. Fidel;Roberto Romero;Norbert Wolf;Jessica Cutright

  • Cytokine and Chemokine Production by Human Oral and Vaginal Epithelial Cells in Response to Candida albicans

    Chad Steele;Paul L. Fidel

  • History and update on host defense against vaginal candidiasis.

    Paul L. Fidel

  • Immunity to Candida.

    PL Fidel

  • Candida albicans Pathogenesis: Fitting Within the “Host-Microbe Damage Response Framework”

    Mary Ann Jabra-Rizk;Eric F. Kong;Christina Tsui;M. Hong Nguyen

  • Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis.

    Brian M. Peters;Glen E. Palmer;Andrea K. Nash;Elizabeth A. Lilly

  • Animal models of mucosal Candida infection.

    Julian R. Naglik;Paul L. Fidel;Frank C. Odds

  • Immunity in vaginal candidiasis

    Paul L Fidel

  • The Host Cytokine Responses and Protective Immunity in Oropharyngeal Candidiasis

    A. Dongari-Bagtzoglou;P.L. Fidel

  • Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis.

    P L Fidel;M E Lynch;J D Sobel

  • Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.

    P L Fidel

  • Transcriptomic Analysis of Vulvovaginal Candidiasis Identifies a Role for the NLRP3 Inflammasome

    Vincent M. Bruno;Amol C. Shetty;Junko Yano;Paul L. Fidel

  • Candida-Host Interactions in HIV Disease Implications for Oropharyngeal Candidiasis

    Fidel Pl

  • Growth Inhibition of Candida albicans by Human Vaginal Epithelial Cells

    Melissa M. Barousse;Chad Steele;Kathleen Dunlap;Terri Espinosa

  • Distinct protective host defenses against oral and vaginal candidiasis.

    Paul L. Fidel

Frequent Co-Authors

Jack D. Sobel
Jack D. Sobel Wayne State University
Chad Steele
Chad Steele Tulane University
Roberto Romero
Roberto Romero National Institutes of Health
Ricardo Gomez
Ricardo Gomez Pontificia Universidad Católica de Chile
Julian R. Naglik
Julian R. Naglik King's College London
David H. Martin
David H. Martin Louisiana State University Health Sciences Center New Orleans
Stephen Challacombe
Stephen Challacombe King's College London
Mary Ann Jabra-Rizk
Mary Ann Jabra-Rizk University of Maryland, Baltimore
Mark C. Herzberg
Mark C. Herzberg University of Minnesota
Cornelius J. Clancy
Cornelius J. Clancy University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding into healthcare roles can provide greater career flexibility. Nursing is a common pathway that complements immunological expertise. Many professionals start with the best online BSN programs for non nurses, which offer tailored curriculums for those entering nursing from different fields.

Accelerated programs like the easiest ABSN programs to get into are also gaining popularity, allowing students with prior degrees to transition quickly into nursing roles. This makes it easier for immunology graduates to pivot toward hands-on patient care while utilizing their scientific background.

For those seeking faster entry points into healthcare, LPN programs easy to get into provide foundational nursing skills with shorter training periods. This can be a practical stepping stone toward more advanced roles involving immunological care and research.

Finally, with growing demand for advanced practice nurses, exploring the easiest online nurse practitioner programs offers a pathway to specialized clinical roles. These programs merge scientific knowledge and patient care, often appealing to those with immunology backgrounds aiming for leadership in healthcare.

Best Scientists Citing Paul L. Fidel

Trending Scientists

Recently Published Articles